New Evidence Available
Updated Recommendation
A new evidence synthesis was published:2018, Updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV
View latest version (2018)Bibliographic information
GuidelineAntiretroviral therapy of HIV infection in infants and children: towards universal access: recommendations for a public health approach 2010 revision
Year of Publication2010
Issuing InstitutionWHO
Recommendation
Retired
For infants exposed to maternal or infant nevirapine (NVP) or other non-nucleoside reverse transcriptase inhibitor (NNRTI) used for maternal treatment or PMTCT, start ART with lopinavir/ritonavir (LPV/r) + 2 nucleoside reverse transcriptase inhibitor (NRTI).
Recommended in favor
Strong
Certainty of evidence
Moderate